FDA Approves New Antibiotic to Treat Community-Acquired Bacterial Pneumonia
The Food and Drug Administration (FDA) announces it has approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another option for the treatment of patients…